Mate Knabe, Torsten Beyna, Thomas Rösch, Jacques Bergman, Hendrik Manner, Andrea May, Guido Schachschal, Horst Neuhaus, Jennis Kandler, Bas Weusten, Oliver Pech, Siegbert Faiss, Mario Anders, Michael Vieth, Susanne Sehner, Raf Bisschops, Pradeep Bhandari, Christian Ell, Hanno Ehlken
INTRODUCTION: The current therapy of neoplastic Barrett's esophagus (BE) consists of endoscopic resection plus ablation, with radiofrequency ablation as the best studied technique. This prospective trial assesses a potential alternative, namely hybrid argon plasma ablation. METHODS: Consecutive patients with neoplastic BE undergoing ablation after curative endoscopic resection (89.6%) or primarily were included into this prospective trial in 9 European centers. Up to 5 ablation sessions were allowed for complete eradication of BE (initial complete eradication of intestinal metaplasia [CE-IM]), by definition including BE-associated neoplasia, documented by 1 negative endoscopy with biopsies...
January 1, 2022: American Journal of Gastroenterology